Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma
Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The study is a prospective, single-center, open-label, single-armed, phase II clinical trial.
The aim of the study is to evaluate the radiological response rate (RR) of 2 cycles of
neoadjuvant chemotherapy with pemetrexed and cisplatin in patients with resectable stage II
and IIIA lung adenocarcinoma.